share_log

上海医药(601607.SH):劳拉西泮片通过仿制药一致性评价

Shanghai Pharmaceutical (601607.SH): Lorazepam tablets passed generic drug consistency evaluation

Gelonghui Finance ·  Apr 9 05:13

Gelonghui, April 9 | Shanghai Pharmaceutical (601607.SH) announced that its holding subsidiary Shandong Xinyi Pharmaceutical Co., Ltd. received the “Drug Supplement Application Approval Notice” issued by the State Drug Administration for lorazepam tablets. The drug passed the consistent evaluation of the quality and efficacy of generic drugs. Lorazepam tablets are mainly used to treat anxiety disorders or for short-term treatment of anxiety symptoms and anxiety associated with depression. They were developed by VALEANTINTL and first marketed in the US in 1977.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment